Steris (Steris) Shares Outstanding (Diluted Average)

: 99 Mil (As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Steris's average diluted shares outstanding for the quarter that ended in Dec. 2023 was 99 Mil.

Steris Shares Outstanding (Diluted Average) Historical Data

The historical data trend for Steris's Shares Outstanding (Diluted Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steris Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Shares Outstanding (Diluted Average)

85.47

85.64

85.90

98.33

100.25

Steris Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Shares Outstanding (Diluted Average)																100.17	101.22	99.24	99.41	99.35

Steris Shares Outstanding (Diluted Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

Steris (NYSE:STE) Shares Outstanding (Diluted Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.

Steris Shares Outstanding (Diluted Average) Related Terms

Thank you for viewing the detailed overview of Steris's Shares Outstanding (Diluted Average) provided by GuruFocus.com. Please click on the following links to see related term pages.

Steris (Steris) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (NYSE:STE) » Definitions » Shares Outstanding (Diluted Average)

Comparable Companies

Traded in Other Exchanges

S1TE34:Brazil

Address

5960 Heisley Road, Mentor, OH, USA, 44060

Website

https://www.steris-ir.com

Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.

Executives

Richard C Breeden	director	100 SOUTH WACKER, SUITE 1800, CHICAGO IL 60606
Cynthia L Feldmann	director	17 WINTHROP ROAD, WAYLAND MA 01778
Jacqueline B Kosecoff	director	5960 HEISLEY ROAD, MENTOR OH 44060
Mohsen Sohi	director	C/O STERIS CORPORATION, 5960 HEISLEY ROAD, MENTOR OH 44060
Esther M. Alegria	director	2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780
Cary L Majors	officer: VP, N America Com Operations	5960 HEISLEY ROAD, MENTOR OH 44060
John Adam Zangerle	director, officer: Sr. VP, Gen Counsel, and Sec.	5960 HEISLEY ROAD, MENTOR OH 44060
Michael J Tokich	director, officer: Sr. Vice Pres., CFO	C/O STERIS CORP, 5960 HEISLEY RD, MENTOR OH 44060
Karen L Burton	officer: VP, Controller & CAO	5960 HEISLEY ROAD, MENTOR OH 44060
Renato Tamaro	officer: V.P. & Corporate Treasurer	5960 HEISLEY ROAD, MENTOR OH 44060
Andrew Xilas	officer: SVP and GM, Dental	5960 HEISLEY ROAD, MENTOR OH 44060
Paul Edward Martin	director	C/O UNISYS CORPORATION, 801 LAKEVIEW DRIVE, SUITE 100, BLUE BELL PA 19422
Julia Madsen	officer: Senior VP, Life Sciences	5960 HEISLEY ROAD, MENTOR OH 44060
David B Lewis	director
Rosebrough Walter M Jr	officer: President & CEO	5960 HEISLEY ROAD, MENTOR OH 44060